ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019
Conceptual Model for Accrual to Cancer Clinical Trials.
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Real-world evaluation of user engagement with an artificial intelligence-powered clinical trial application in oncology.Journal of the American Medical Informatics Association : JAMIA · 2025Article
- Old drugs, new challenges: reassigning drugs for cancer therapies.Cellular & molecular biology letters · 2025Review
- Characterization of terminated and withdrawn clinical trials for the treatment and prevention of oral mucositis.Journal of clinical and translational science · 2025Article
- Exploring two tumor treatment strategies: effectiveness of ribosome inactivating proteins and mesenchymal stem cells/MSC derived extracellular vesicles in cancer treatment.Frontiers in oncology · 2025Review
- Facilitation of Enrollment onto Cancer Clinical Trials Using a Novel Navigator-Assisted Program: A Cross-Sectional Study.Current oncology (Toronto, Ont.) · 2024Article
- Identifying and addressing a new barrier to community-based patients accessing cancer clinical trials.Contemporary clinical trials communications · 2024Article
- Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy.British journal of cancer · 2024Review
- Enrolling Older Adults Onto National Cancer Institute-Funded Clinical Trials in Community Oncology Clinics: Barriers and Solutions.Journal of the National Cancer Institute. Monographs · 2022Article
- Through the Lens of Patient Partners: Challenges in Accrual of Older Adults to NCI Clinical Trials.Journal of the National Cancer Institute. Monographs · 2022Article
- Better Late Than Never: Fully Incorporating Oncology Advanced Practice Providers Into Cancer Clinical Trials.JCO oncology practice · 2022Article
- Clinical Research Professional Providing Care Coordination Support: A Study of Hawaii Minority/Underserved NCORP Community Site Trial Participants.JCO oncology practice · 2022Article
- Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition.Nature medicine · 2022Article
- Role of Oncology Advanced Practitioners to Enhance Clinical Research.Journal of the advanced practitioner in oncology · 2022Article
- Machine learning applications for therapeutic tasks with genomics data.Patterns (New York, N.Y.) · 2021Review
- A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006).Breast cancer research and treatment · 2021Article
- Reimbursement Matters: Overcoming Barriers to Clinical Trial Accrual.Medical care · 2021Article
- How to Simplify the Evaluation of Newly Introduced Chemotherapeutic Interventions in Myeloma.Clinical hematology international · 2021Article
- Building a Fit for Purpose Clinical Trials Infrastructure to Accelerate the Assessment of Novel Hematopoietic Cell Transplantation Strategies and Cellular Immunotherapies.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.